title: Pancreatic endocrine function in patients treated with ciclosporine, azathioprine and prednisone after kidney transplantation.
authors.forename: E
authors.initials: E
authors.lastname: Zukowska-Szczechowska
authors.forename: W
authors.initials: W
authors.lastname: Grzeszczak
authors.forename: F
authors.initials: F
authors.lastname: Kokot
authors.forename: T
authors.initials: T
authors.lastname: Nieszporek
authors.forename: S
authors.initials: S
authors.lastname: Kuśmierski
authors.forename: R
authors.initials: R
authors.lastname: Kurzbauer
authors.forename: A
authors.initials: A
authors.lastname: Szkodny
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005934:Glucagon / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy; D007328:Insulin / Q000097:blood; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000601:surgery; D016030:Kidney Transplantation; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000503:physiopathology*; D010191:Pancreatic Polypeptide / Q000097:blood; D011241:Prednisone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D003524:Cyclosporins; D007328:Insulin; D010191:Pancreatic Polypeptide; D005934:Glucagon; D001379:Azathioprine; D011241:Prednisone